Stay updated on EAGLE Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck Cancer
Sign up to get notified when there's something new on the EAGLE Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck Cancer page.

Latest updates to the EAGLE Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck Cancer page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe PubMed publications description was simplified from a statement that publications are automatically created by ClinicalTrials.gov using the NCT number to a note that PubMed publications are automatically filled from PubMed and may not be about the study; the revision version is updated to Rev. 3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check28 days agoChange DetectedThe page previously displayed a government funding status notice; that notice has been removed without altering trial data, eligibility criteria, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedThe two screenshots of the Study Details page show only minor layout and wording adjustments; core study information such as title, interventions, primary and secondary outcomes, eligibility criteria, and enrollment remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check71 days agoChange DetectedUpdate includes a critical operating-status notice and an upgraded version identifier to v3.2.0, replacing the previous v3.1.0.SummaryDifference2%

- Check78 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.0%

- Check92 days agoChange DetectedUpdate to v3.0.2 was added; the previous v3.0.1 label was removed, and the Back to Top element was deleted.SummaryDifference0.1%

Stay in the know with updates to EAGLE Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck Cancer
Enter your email address, and we'll notify you when there's something new on the EAGLE Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck Cancer page.